Phaos Technology Holdings (Cayman) (POAS) Total Current Liabilities (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Total Current Liabilities of $4.7 million for Q4 2025, up 65.19% on a QoQ basis from $2.8 million in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Total Current Liabilities (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Total Current Liabilities history runs 2 years deep, the most recent figure standing at $4.7 million for Q4 2025.
- Quarterly Total Current Liabilities changed N/A year-over-year to $4.7 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $4.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.8 million, up 87.19% from the prior year.
- Total Current Liabilities was $4.7 million for Q4 2025 at Phaos Technology Holdings (Cayman), up from $2.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $4.7 million in Q4 2025 and bottomed at $1.5 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.05 Mn | 5.99 Mn | - | 4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 4.69 Mn |
| Apr 30, 2025 | 2.84 Mn |
| Apr 30, 2024 | 1.52 Mn |